Elsevier

Kidney International

Volume 90, Issue 4, October 2016, Pages 740-745
Kidney International

Mini Review
Nanomedicines for kidney diseases

https://doi.org/10.1016/j.kint.2016.03.041Get rights and content
Under an Elsevier user license
open archive

Nanomedicines have been the subject of great interest for the treatment, diagnosis, and research of disease; however, few specifically address kidney disorders. Nanotechnology can confer significant benefits to medicine, such as the targeted delivery of drugs to specific tissues. Nanomedicines in the clinic have increased drug solubility, reduced off-target side effects, and provided novel diagnostic tools. There is an increasing cohort of nanomaterials that may have implications for kidney disease. Here, we review nanomaterial properties that are potentially applicable to kidney research and therapy, and we highlight clinical areas of need that may benefit from kidney nanomedicines.

Keywords

diagnostics
drug development
imaging
nanoparticles
theranostics
therapeutics

Cited by (0)